We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBAN icon
3501
Colony Bankcorp
CBAN
$468M
$1.66M ﹤0.01%
100,367
-1,148
-1% -$18.1K
RIBT
3502
DELISTED
RiceBran Technologies
RIBT
$1.64M ﹤0.01%
111,801
+13,795
+14% +$325K
MHH icon
3503
Mastech Digital
MHH
$95.7M
$1.64M ﹤0.01%
147,674
CMT icon
3504
Core Molding Technologies
CMT
$216M
$1.63M ﹤0.01%
500,069
RNGR icon
3505
Ranger Energy Services
RNGR
$375M
$1.62M ﹤0.01%
251,582
+71
+0% +$445
APT icon
3506
Alpha Pro Tech
APT
$53.3M
$1.62M ﹤0.01%
471,840
ATXI
3507
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$1.61M ﹤0.01%
149
+27
+22% +$189K
PAVM icon
3508
PAVmed
PAVM
$35.4M
$1.6M ﹤0.01%
2,970
-7
-0.2% -$2.92K
SRTS icon
3509
Sensus Healthcare
SRTS
$49.1M
$1.6M ﹤0.01%
451,597
+400
+0.1% +$1.81K
GNCA
3510
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.6M ﹤0.01%
771,922
CLPT icon
3511
ClearPoint Neuro
CLPT
$408M
$1.59M ﹤0.01%
332,017
+87,674
+36% +$363K
MN
3512
DELISTED
MANNING & NAPIER, INC.
MN
$1.59M ﹤0.01%
912,966
INSE icon
3513
Inspired Entertainment
INSE
$177M
$1.59M ﹤0.01%
235,179
-2,040
-0.9% -$14.6K
REKR icon
3514
Rekor Systems
REKR
$89M
$1.59M ﹤0.01%
415,344
+87,500
+27% +$218K
MACK
3515
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.58M ﹤0.01%
503,027
+8,000
+2% +$32K
AINC
3516
DELISTED
Ashford Inc.
AINC
$1.57M ﹤0.01%
66,432
+14,166
+27% +$337K
SPT icon
3517
Sprout Social
SPT
$492M
$1.56M ﹤0.01%
+97,420
New +$1.58M
CSPI icon
3518
CSP Inc
CSPI
$83.2M
$1.55M ﹤0.01%
237,270
LMST
3519
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$1.54M ﹤0.01%
85,622
+2,517
+3% +$40.7K
VIVS
3520
VivoSim Labs
VIVS
$1.15M
$1.54M ﹤0.01%
18,020
+3
+0% +$281
MMAT
3521
DELISTED
Meta Materials Inc. Common Stock
MMAT
$1.53M ﹤0.01%
10,096
+20
+0.2% +$3.32K
OPNT
3522
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$1.53M ﹤0.01%
106,322
CSSE
3523
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$1.53M ﹤0.01%
191,014
VNRX icon
3524
VolitionRx Ltd
VNRX
$9.23M
$1.52M ﹤0.01%
16,063
LGL icon
3525
LGL Group
LGL
$48.1M
$1.52M ﹤0.01%
268,518
+32,811
+14% +$155K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.